Franklin Resources
PLRX icon

Franklin Resources’s Pliant Therapeutics PLRX Stock Holding History

Franklin Resources’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,583
Closed -$48K – 3109
2025
Q1 		$48K Sell
35,583
-1,009,994
-97% -$6.13M ﹤0.01% 2860
2024
Q4 		$13.8M Buy
1,045,577
+5,673
+0.5% +$77.5K ﹤0.01% 1018
2024
Q3 		$14.3M Buy
1,039,904
+14,913
+1% +$187K ﹤0.01% 997
2024
Q2 		$11M Sell
1,024,991
-511,859
-33% -$6.6M ﹤0.01% 1038
2024
Q1 		$22.9M Sell
1,536,850
-42,722
-3% -$705K 0.01% 823
2023
Q4 		$28.6M Buy
1,579,572
+62,173
+4% +$945K 0.01% 666
2023
Q3 		$26.3M Buy
1,517,399
+17,075
+1% +$296K 0.01% 668
2023
Q2 		$27.2M Buy
1,500,324
+11,123
+0.7% +$263K 0.01% 691
2023
Q1 		$39.6M Sell
1,489,201
-243
-0% -$6.92K 0.02% 600
2022
Q4 		$28.8M Sell
1,489,444
-2,739
-0.2% -$57.3K 0.02% 677
2022
Q3 		$31.2M Buy
1,492,183
+1,057,440
+243% +$20.2M 0.02% 658
2022
Q2 		$3.48M Buy
434,743
+528
+0.1% +$3.38K ﹤0.01% 1193
2022
Q1 		$3.04M Hold
434,215
– – ﹤0.01% 1288
2021
Q4 		$5.86M Buy
434,215
+37,706
+10% +$599K ﹤0.01% 1178
2021
Q3 		$6.69M Hold
396,509
– – ﹤0.01% 1142
2021
Q2 		$11.5M Buy
396,509
+46,500
+13% +$1.45M ﹤0.01% 988
2021
Q1 		$13.8M Hold
350,009
– – 0.01% 918
2020
Q4 		$7.95M Buy
350,009
+9
+0% +$226 ﹤0.01% 1006
2020
Q3 		$7.93M Hold
350,000
– – ﹤0.01% 957
2020
Q2 		$8.92M Buy
+350,000
New +$9.29M ﹤0.01% 894

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Franklin Resources's PLRX Position: Q2 2025 in Review

Franklin Resources sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 35,583 shares — an estimated $48K sold.

Franklin Resources first reported a position in PLRX in Q2 2020 and held it in 20 quarters. The position peaked at $39.6M in Q1 2023. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Franklin Resources reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Franklin Resources sold 35,583 Pliant Therapeutics shares in Q2 2025, an estimated $48K.
  • Franklin Resources first reported a position in Pliant Therapeutics in Q2 2020 and held it in 20 quarters.
  • Franklin Resources's Pliant Therapeutics position peaked at $39.6M in Q1 2023.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Franklin Resources's 13F filing for Q2 2025, filed 12 Aug 2025.